ВАСКУЛЯР ПАРКИНСОНИЗМ РИВОЖЛАНИШИНИНГ ЭТИОПАТОГЕНЕТИК ЖИХАТЛАРИ (АДАБИЁТЛАР ШАРҲИ)
##article.subject##:
паркинсонизм, қон томир, эндотелий##article.abstract##
Мақолада сурункали васкуляр паркинсонизм ривожланишининг этиопатогенетик жихатлари ҳакида адабиётлар шарҳи берилган. Касаллик ривожланишида эндотелиал дисфункция ҳамияти ёритиб берилган.
Библиографические ссылки
Исхакова Э.В. Возможности магнитно-резонансной морфометрии в диагностике изменений головного мозга при нейродегенеративных заболеваниях, сопровождающихся синдромом паркинсонизма // Автореферат диссертации. 2021, РФ.
Карабань И.Н. Сосудистый паркинсонизм: возможность и/или объективная реалность // Международный неврологический журнал, Украниа 2016.- №3 (81). – С. 25-31.
Кумаханов А.А., Тлапшокова Л.Б., Дудуев У.С. Сovid-19 и сосудистый паркинсонизм. разбор клинического случая // Ествественные и технические науки,2023. -№8. – С. 175-177.
DK Khaydarova, HZ Davronova. Cognitive deficit in stage ii cerebrovascular accident in patients with Рarkinson's syndrome. Global research and academic innovations. 2026/3/6. Р.201-204
Шиндряева, Н.Н. Сосудистый паркинсонизм в амбулаторной практике // Терапия. - 2018. - № 7-8 (25-26). - С. 77-81.
Khodjieva D. T., Khaydarova D. K., Khaydarov N. K. Diagnosis and treatment of early stage parkinson's disease. European Journal of Research. 2017. P. 43-52
Caba, L.M., Ferrairó, JIT, Torres, IM, et al. Increased pulsatility index supports diagnosis of vascular parkinsonism versus idiopathic Parkinson’s disease. Neurologia (Engl Ed) 2020;35:563–567.CrossRefGoogle ScholarPubMed
Cavallieri F, Fioravanti V, Bove F, et al. COVID-19 and Parkinsonism: A Critical Appraisal. Biomolecules. 2022;12(7):970. Published 2022 Jul 11.
Compeer MG, Suylen DP, Hackeng TM, et al. Endothelin-1 and -2: two amino acids matter. Life Sci. 2012; 91: 607-12.
Davenport A.P. Endothelin // Pharmacol Rev. – 2016. – Vol. 68, № 2. – P. 357-418.
Dunet, V. MRI volumetric morphometry in vascular parkinsonism / V. Dunet, J. Deverdun, C. Charroud [et al.] // J Neurol. - 2017. - Vol. 264, N 7. - P. 15111519.
Endothelin-1-induced endoplasmic reticulum stress in Parkinson's disease Pharmacologia. 2014; 5:84-90.
Giliberto, C, Mostile, G, Lo Fermo, S, et al. Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis. Neurol Sci 2017;38:2209–2212.CrossRefGoogle ScholarPubMed
Rektor, I, Bohnen, NI, Korczyn, AD, et al. An updated diagnostic approach to subtype definition of vascular parkinsonism – recommendations from an expert working group. Parkinsonism Relat Disord 2017;49:9–16.CrossRefGoogle ScholarPubMed
Jellinger K.A. The enigma of vascular cognitive disorder and vascular dementia // Acta Neuropathol (Berl). – 2007. – Vol. 113. №4 – Р.349-388.
Kim J.-S., Lee K.-S., Song I.-U., et al. Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. // Journal of the Neurological Sciences. — 2008. — Vol. 270, № 1-2. — Р. 122-126.
Ma, KKY, Lin, S, Mok, VCT. Neuroimaging in vascular parkinsonism. Curr Neurol Neurosci Rep 2019;19:102.CrossRefGoogle ScholarPubMed
Marxreiter, F.Vaskuläres Parkinson-Syndrom (Parkinsonismus bei vaskulärer Enzephalopathie) / F. Marxreiter, J. Winkler // Fortschr Neurol Psychiatr. - 2016. - Vol. 84, Suppl 1. - S. 8-13.
Meijer, F.J. Clinical application of brain MRI in the diagnostic work-up of parkinsonism / F.J. Meijer, B. Goraj, B.R. Bloem [et al.] // J. parkinsons dis. - 2017. -Vol. 7. - P. 211-217.
Mostile, G, Nicoletti, A, Cicero, CE, et al. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism. Neurol Sci 2016;37:591–595.CrossRefGoogle ScholarPubMed
Mostile, G. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism / G. Mostile, A. Nicoletti, C.E. Cicero [et al.] // Neurol Sci. - 2016. - Vol. 37. - P. 591-595
Mostile, G, Nicoletti, A, Zappia, M. Vascular parkinsonism: still looking for a diagnosis. Front Neurol 2018;9:411.CrossRefGoogle ScholarPubMed
Nowacka B, Lubiсski W, Karczewicz D. Ophthalmological and electrophysiological features of Parkinson’s disease. Klinika Oczna. 2010; 112(7-9):247-252.
Pradhan, S. Sieve-like basal ganglia: A rare MRI presentation of vascular parkinsonism / S. Pradhan, R. Bansal // Neurol India. - 2018. - Vol. 66, N 3. - P. 878879.
Sako, W. «One line»: A method for differential diagnosis of parkinsonian syndromes / W. Sako, T. Abe, S. Haji [et al.] // Acta. neurologica Scandinavica. - 2019. - Vol. 140. - P. 229-235.
Salsone, M. Microstructural changes of normal-appearing white matter in vascular parkinsonism / M. Salsone, M.E. Caligiuri, V. Vescio [et al.] // Parkinsonism Relat Disord. - 2019. - Vol. 63. - P. 60-65.
Spiegel J., Hellwig D., Farmakis G., et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. // Movement Disorders. 2007. — Vol. 22, №7. — Р.1004-1008.
Spiegel J., Möllers M.-O., Jost W. H., et al. FP-CIT and MIBG scintigraphy in early Parkinson’s disease. // Movement Disorders. — 2005. — Vol. 20, №5. — Р. 552-561.
Sulzer D, Antonini A, Leta V, et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis. 2020; 6:18. Published 2020 Aug 20.
Udagedara, TB, Dhananjal Alahakoon, AM, Goonaratna, IK. Vascular parkinsonism: a review on management updates. Ann Indian Acad Neurol 2019;22:17–22.Google ScholarPubMed
Udagedara T.B., Goonaratna I.K. Vascular parkinsonism: a review on management updates. Ann Indian Acad Neurol 2019;22:17–20.
Vale T.C., Caramelli P, Cardoso F. Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease. J Neurol Neurosurg Psychiatry. 2015 May;86(5):547-53.
Vizcarra, JA, Lang, AE, Sethi, KD, Espay, AJ. Vascular parkinsonism: deconstructing a syndrome. Mov Disord 2015;30:886–894.CrossRefGoogle ScholarPubMed
Zhang, S, Wang, Y, Liu, L. et al. Case report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and behavioral disturbance. BMC Neurol 2021;21:15.CrossRefGoogle ScholarPubMed.
Zhao X.J. Signal alteration of substantia nigra on 3.0T susceptibility-weighted imaging in Parkinson's disease and vascular parkinsonism / X.J. Zhao, X.Y. Niu, H.Y. You [et al.] // Curr. med. sci. - 2019. - Vol. 39, N 5. - P. 831-835.